Immunomodulatory effects of coated gold nanoparticles in LPS-stimulated in vitro and in vivo murine model systems.

The ability of nanoparticle surface functionalities to regulate immune responses during an immunological challenge (i. e. inflammation) would open new doors for their use in non-prophylactic therapeutics. We report here the use of functionalized 2 nm core gold nanoparticles to control the immunological responses of in vitro and in vivo systems presented with an inflammatory challenge. The results showed that NPs bearing a hydrophobic zwitterionic functionality boost inflammatory outcomes while hydrophilic zwitterionic NPs generate minimal immunological responses. Surprisingly, tetra(ethylene glycol) headgroups generate a significant anti-inflammatory response both in vitro and in vivo. These results demonstrate the ability of simple surface ligands to provide immunomodulatory properties, making them promising leads for the therapeutic usage of nanomaterials in diseases involving inflammation.

[1]  W. Jiskoot,et al.  Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[2]  M. Akashi,et al.  Manipulating the antigen-specific immune response by the hydrophobicity of amphiphilic poly(γ-glutamic acid) nanoparticles. , 2013, Biomaterials.

[3]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[4]  Junjie Xu,et al.  Surface hydrophobicity of microparticles modulates adjuvanticity. , 2013, Journal of materials chemistry. B.

[5]  Michael Karin,et al.  Reactive Oxygen Species Promote TNFα-Induced Death and Sustained JNK Activation by Inhibiting MAP Kinase Phosphatases , 2005, Cell.

[6]  D. Schwartz,et al.  Toll-Like Receptor 4 (TLR4)-Deficient Murine Macrophage Cell Line as an In Vitro Assay System To Show TLR4-Independent Signaling of Bacteroides fragilis Lipopolysaccharide , 2002, Infection and Immunity.

[7]  Richard A Flavell,et al.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. , 2009, Vaccine.

[8]  Shaoyi Jiang,et al.  Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production , 2014 .

[9]  Guanghui Ma,et al.  Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation. , 2014, Biomaterials.

[10]  P. Libby.  Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. , 2000, The American journal of cardiology.

[11]  Shaoyi Jiang,et al.  Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles , 2012 .

[12]  R. Serda.  Particle platforms for cancer immunotherapy , 2013, International journal of nanomedicine.

[13]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[14]  Neus G Bastús,et al.  Peptides conjugated to gold nanoparticles induce macrophage activation. , 2009, Molecular immunology.

[15]  Jean Paul Remon,et al.  Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection. , 2012, ACS nano.

[16]  Dan Peer,et al.  Nanoparticle hydrophobicity dictates immune response. , 2012, Journal of the American Chemical Society.

[17]  Bo Yan,et al.  Fabrication of Corona-Free Nanoparticles with Tunable Hydrophobicity , 2014, ACS nano.

[18]  A. Vernallis,et al.  Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipoteichoic acid and related cell wall antigens from Staphylococcus epidermidis. , 2005, Journal of medical microbiology.

[19]  John Samuel,et al.  Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Vincent M Rotello,et al.  The role of surface functionality on acute cytotoxicity, ROS generation and DNA damage by cationic gold nanoparticles. , 2010, Small.

[21]  Gert Storm,et al.  Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system , 1995 .

[22]  Karen L Wooley,et al.  Cytokines as biomarkers of nanoparticle immunotoxicity. , 2013, Chemical Society reviews.

[23]  Vincent M Rotello,et al.  Nano meets biology: structure and function at the nanoparticle interface. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[24]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[25]  Sai T Reddy,et al.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.

[26]  James J Moon,et al.  Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.

[27]  M. Feldmann,et al.  TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases , 2003, Nature Medicine.

[28]  Krishnendu Roy,et al.  Materials that harness and modulate the immune system , 2014, MRS bulletin.

[29]  Justin E. Juskewitch,et al.  Disparate roles of marrow- and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation , 2012, Scientific Reports.

[30]  J. Lampa,et al.  Evidence of central inflammation in fibromyalgia — Increased cerebrospinal fluid interleukin-8 levels , 2012, Journal of Neuroimmunology.

[31]  V. Rotello,et al.  Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles , 2011, PloS one.

[32]  Jeffrey A. Hubbell,et al.  Materials engineering for immunomodulation , 2009, Nature.

[33]  G. Panayi,et al.  Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.

[34]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[35]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[36]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.